Furthermore, we are unaware of any study linking DVL2 gene expression to psychosis or other major psychiatric disorders, although numerous studies have implicated GSK3B in the pathogenesis of schizophrenia as well as antipsychotic drug action [1]. This evidence concerns the gene GSK3B and psychiatric disorder.